RxDoctor Payments Data

Lauren Havard, MD

Family Medicine · Phoenix, AZNPI 1053844597

Payments from drug & device makers

$3,584in general payments, 2019–2025

Across 104 payments — averaging $34.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$854
  • AstraZeneca$660
  • Lucid Diagnostics Inc.$399
  • Novo Nordisk$358
  • Abbott$189
  • Medtronic$168
  • plus $957 from 21 others

What the payments were for

  • Food & beverage$3,584100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,584 in reported general payments places this provider in the 85th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$23,307
Medicare patients
47
Services billed
398

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin20$27,080
TrulicityDulaglutide18$22,249
OzempicSemaglutide15$21,436
EliquisApixaban17$19,772
Breztri AerosphereBudesonide/Glycopyr/Formoterol29$18,957
FarxigaDapagliflozin Propanediol23$18,238
MounjaroTirzepatide15$16,163
Rosuvastatin Calcium63$1,246
Albuterol Sulfate HfaAlbuterol Sulfate67$1,085
Atorvastatin Calcium117$1,083
Levothyroxine Sodium111$1,057
ValacyclovirValacyclovir Hcl25$853
Amlodipine Besylate127$763
Omeprazole27$752
Escitalopram Oxalate44$744

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$70$38,41233 claims
AstraZenecaBreztri Aerosphere, Farxiga$660$37,19452 claims
Novo NordiskOzempic$358$21,43615 claims
PfizerEliquis$51$19,77217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →